SPECIAL NOTICE
99 -- Amendment 1 to the Solicitation - Operate, Maintain and Improve the existing Proteomic Data Commons (PDC)
- Notice Date
- 6/16/2023 8:27:22 AM
- Notice Type
- Special Notice
- Contracting Office
- NIH NCI Bethesda MD 20892 USA
- ZIP Code
- 20892
- Response Due
- 9/29/2023 2:00:00 PM
- Archive Date
- 10/14/2023
- Point of Contact
- Connor Cigrang
- E-Mail Address
-
Connor.cigrang@nih.gov
(Connor.cigrang@nih.gov)
- Description
- This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR). The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024, which provides Operations and Technical Support (OTS) for the FNLCR. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings. Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. A Special Notice for the Leidos Biomedical Research �Request for Proposal (RFP) S23-072 to Maintain, Operate, and Improve the PDC� was previously posted to SAM.gov on May 16, 2023. (https://sam.gov/opp/cda50ba1ffb945e3b7505229a825b92f/view#general) . Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick.� The effort to be performed will be part of Leidos Biomed�s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD. Description of Work - National Cancer Institute�s Proteomic Data Commons (PDC) is the largest public repository of comprehensive tumor proteomic datasets. It�s a cloud-based resource that collects, harmonizes, and hosts mass spectrometry-based proteomic data along with corresponding metadata across a variety of tumor types from programs including Clinical Proteomic Tumor Analysis Consortium (CPTAC), International Cancer Proteogenome Consortium (ICPC) and the Applied Proteogenomics Organizational Learning and Outcomes (APOLLO) network. The PDC data portal is open access and provides end users with appropriate compute capacity to support large-scale analytical capabilities. PDC also maps datasets, when available, to corresponding genomic and/or imaging data within the NCI Cancer Research Data Commons (CRDC). Objectives - The objectives of Proteomic Data Commons (PDC) are (1) to make cancer-related proteomic datasets easily accessible to the public, and (2) to facilitate direct multi-omics integration in support of precision medicine through interoperability with accompanying data resources (such as genomic and medical image datasets). The scope of this Statement of Work (SOW) is to operate, maintain and improve the existing Proteomic Data Commons (PDC). The PDC has been available to the scientific community for over 3 years. It is part of the CRDC data ecosystem and is expected to utilize all the relevant CRDC interoperability requirements such as Cancer Data Aggregator. Areas influenced by these requirements include system design, PDC data model, data sharing, Application Programming Interfaces (APIs) and communication activities. Since the PDC has already completed development and has been released in a production environment, the main activities will be continued operations of PDC along with necessary enhancements due to the new data types (such as metabolomics) and to improve data utilization and interoperability. To obtain a full copy of the formal solicitation please contact�Connor Cigrang at connor.cigrang@nih.gov.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/4511197d408f41b0805a9135405ef75b/view)
- Record
- SN06718601-F 20230618/230616230106 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |